Mannheim, Germany

Elena Willig

This inventor holds 1 USPTO granted patent. Top assignee: Previpharma Consulting Gmbh. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elena Willig. Retrieved from https://idiyas.com/inventor/elena-willig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elena Willig - Innovator in Lung Dysfunction Treatment

Introduction

Elena Willig is a prominent inventor based in Mannheim, Germany. She has made significant contributions to the field of medical science, particularly in the treatment of lung dysfunction. Her innovative approach has led to the development of a unique method that addresses critical health issues.

Latest Patents

Elena Willig holds a patent for her invention titled "Plasminogen for use in treating and preventing lung dysfunction." This invention relates to the use of plasminogen in a method for treating or preventing lung dysfunction associated with the formation of hyaline membranes in patients. The method includes the administration of at least one plasminogen activator, showcasing her commitment to advancing medical treatments.

Career Highlights

Elena is currently associated with Previpharma Consulting GmbH, where she continues to work on innovative solutions in the healthcare sector. Her dedication to research and development has positioned her as a key figure in her field.

Collaborations

Elena collaborates with esteemed colleagues, including Stephan T Kiessig and Ricarda Welz. These partnerships enhance her research efforts and contribute to the advancement of medical science.

Conclusion

Elena Willig's work in the field of lung dysfunction treatment exemplifies her innovative spirit and dedication to improving patient care. Her contributions are paving the way for new therapeutic approaches in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…